Identifying a biomarker to improve care for patients with post-stroke spatial neglect

A biomarker for personalized care in post-stroke spatial neglect

['FUNDING_OTHER'] · NORTHAMPTON VA MEDICAL CENTER · NIH-11173591

This study is working on a new way to help people who have trouble with awareness after a stroke, called spatial neglect, by finding a specific marker that can guide their rehabilitation and improve their recovery.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorNORTHAMPTON VA MEDICAL CENTER (nih funded)
Locations1 site (LEEDS, UNITED STATES)
Trial IDNIH-11173591 on ClinicalTrials.gov

What this research studies

This research focuses on developing a biomarker that can help personalize rehabilitation for patients suffering from spatial neglect, a cognitive deficit that affects their perception and awareness after a stroke. The team aims to enhance the identification of a specific subtype of spatial neglect, known as Aiming SN, which is linked to motor-intentional deficits and can predict better rehabilitation outcomes. By utilizing advanced neuroimaging techniques, the researchers hope to bridge the gap in care delivery for this often underdiagnosed condition, ultimately improving patient outcomes and quality of life. The study builds on over a decade of work in understanding the neuropsychological aspects of spatial neglect and aims to implement more effective rehabilitation protocols.

Who could benefit from this research

Good fit: Ideal candidates for this research are stroke survivors experiencing symptoms of spatial neglect, particularly those with the Aiming SN subtype.

Not a fit: Patients who do not have spatial neglect or those whose cognitive deficits are unrelated to stroke may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective and personalized rehabilitation strategies for stroke patients with spatial neglect, improving their daily functioning and quality of life.

How similar studies have performed: Previous research has shown promise in identifying biomarkers for cognitive deficits, suggesting that this approach could yield valuable insights, although the specific focus on Aiming SN is relatively novel.

Where this research is happening

LEEDS, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.